IBDoc® Canadian User Performance Evaluation

NACompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

May 5, 2017

Primary Completion Date

August 22, 2017

Study Completion Date

August 22, 2017

Conditions
Inflammatory Bowel Diseases
Interventions
DIAGNOSTIC_TEST

IBDoc calprotectin test

Patients are asked to perform a single IBDoc calprotectin home test.

OTHER

questionnaire

Patients evaluate the ease-of-use of the test, clearness of test results and comprehensiveness of the instructions for use through a specific questionnaire implementing Likert scales.

Trial Locations (3)

T6G 2R7

Division of Gastroenterology, Department of Medicine, Faculty of Medicine University of Alberta,, Edmonton

V6Z 2K5

GIRI (GI Research Institute), Vancouver

Unknown

Hôtel-Dieu de Lévis,, Lévis

Sponsors
All Listed Sponsors
lead

Bühlmann Laboratories AG

INDUSTRY

NCT03408249 - IBDoc® Canadian User Performance Evaluation | Biotech Hunter | Biotech Hunter